Dysport is associate injection containing abobotulinumtoxinA (Botulinum poisonous substance sort A). AbobotulinumtoxinA is created from the microorganism that causes gastrointestinal disorder. neurotoxin blocks nerve activity within the muscles, inflicting a brief reduction in muscle activity.
Dysport is employed to treat cervical dystonia (severe spasms within the neck muscles).
Dysport is additionally accustomed quickly reduce the looks of facial wrinkles.
Submit your review
Get emergency medical help if you have signs of an allergic reaction to Dysport: hives; difficulty breathing; feeling like you might pass out; swelling of your face, lips, tongue, or throat.
The botulinum toxin contained in Dysport can spread to other body areas beyond where it was injected. This has caused serious life-threatening side effects in some people receiving botulinum toxin injections, even for cosmetic purposes.
Call your doctor at once if you have any of these side effects, some of which can occur up to several weeks after receiving a Dysport injection:
trouble breathing, talking, or swallowing;
hoarse voice, drooping eyelids;
problems with vision;
unusual or severe muscle weakness (especially in a body area that was not injected with the medication);
loss of bladder control;
crusting or drainage from your eyes;
severe skin rash or itching;
fast, slow, or uneven heartbeats; or
chest pain or heavy feeling, pain spreading to the arm or shoulder, general ill feeling.
Common Dysport side effects may include:
muscle weakness near where the medicine was injected;
bruising, bleeding, pain, redness, or swelling where the injection was given;
headache, muscle pain or stiffness, neck pain;
fever, cough, sore throat, runny or stuffy nose;
drooping eyelids, dry or puffy eyes;
nausea, dry mouth;
trouble swallowing; or
The recommended initial dose of DYSPORT® for the treatment of cervical dystonia is 500 Units given intramuscularly as a divided dose among affected muscles in patients with or without a history of prior treatment with botulinum toxin. (A description of the average DYSPORT® dose and percentage of total dose injected into specific muscles in the pivotal clinical trials can be found in Table 8 of Section 14.1, Clinical Studies – Cervical Dystonia.) Limiting the dose injected into the sternocleidomastoid muscle may reduce the occurrence of dysphagia. Clinical studies with DYSPORT® in cervical dystonia suggest that the peak effect occurs between two and four weeks after injection. Simultaneous EMG-guided application of DYSPORT® may be helpful in locating active muscles.